Smith Group Asset Management, LLC Moderna, Inc. Transaction History

Smith Group Asset Management, LLC

  • $1.21 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
SELL
$69.51 - $104.43 $123,727 - $185,885
-1,780 Closed
0 $0
Q4 2021

Feb 02, 2022
BUY
$225.82 - $368.51 $126,459 - $206,365
560 Added 45.9%
1,780 $452,000
Q3 2021

Nov 12, 2021
BUY
$221.9 - $484.47 $270,718 - $591,053
1,220 New
1,220 $470,000

Others Institutions Holding MRNA

# of Institutions
952
Shares Held
241M
Call Options Held
10.6M
Put Options Held
18.7M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.1B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Smith Group Asset Management, LLC Portfolio

Follow Smith Group Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith Group Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smith Group Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email